 | KUS | Name: | (Z)-N-(4-chlorophenyl)-4-oxidanylidene-but-2-enamide | Formula: | C10 H8 Cl N O2 | SMILES: | Clc1ccc(NC(=O)C=CC=O)cc1 | InChi: | InChI=1S/C10H8ClNO2/c11-8-3-5-9(6-4-8)12-10(14)2-1-7-13/h1-7H,(H,12,14)/b2-1- | Synonyms: | N1-(4-chlorophenyl)-2-butenediamide (reacted form of) | Definition date: | 2022-06-07 | Last modified: | 2024-09-27 | Release date: | 2023-06-14 | Identifier: | (~{Z})-~{N}-(4-chlorophenyl)-4-oxidanylidene-but-2-enamide |
|
 | KUT | Name: | KUT [2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl] | Formula: | C35 H63 N3 O12 | SMILES: | OC(=O)CCCCCCCCCCCCCCCCC(=O)N[CH](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC=O)C(O)=O | InChi: | InChI=1S/C35H63N3O12/c39-21-24-49-26-25-47-23-20-37-33(42)29-50-28-27-48-22-19-36-31(40)18-17-30(35(45)46)38-32(41)15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-34(43)44/h21,30H,1-20,22-29H2,(H,36,40)(H,37,42)(H,38,41)(H,43,44)(H,45,46)/t30-/m0/s1 | Definition date: | 2019-06-28 | Last modified: | 2024-09-27 | Release date: | 2020-07-15 | Identifier: | 18-[[(2~{S})-1-oxidanyl-1,5-bis(oxidanylidene)-5-[2-[2-[2-oxidanylidene-2-[2-[2-(2-oxidanylideneethoxy)ethoxy]ethylamino]ethoxy]ethoxy]ethylamino]pentan-2-yl]amino]-18-oxidanylidene-octadecanoic acid |
|
 | HLU | Name: | BETA-HYDROXYLEUCINE | Formula: | C6 H13 N O3 | SMILES: | O=C(O)C(N)C(O)C(C)C | InChi: | InChI=1S/C6H13NO3/c1-3(2)5(8)4(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t4-,5-/m0/s1 | Definition date: | 2004-02-02 | Last modified: | 2024-09-27 | Identifier: | (2S,3S)-2-amino-3-hydroxy-4-methylpentanoic acid (non-preferred name) |
|
 | HLX | Name: | 5-methyl-L-norleucine | Formula: | C7 H15 N O2 | SMILES: | O=C(O)C(N)CCC(C)C | InChi: | InChI=1S/C7H15NO2/c1-5(2)3-4-6(8)7(9)10/h5-6H,3-4,8H2,1-2H3,(H,9,10)/t6-/m0/s1 | Definition date: | 2013-03-28 | Last modified: | 2024-09-27 | Release date: | 2013-06-12 | Identifier: | 5-methyl-L-norleucine |
|
 | HM3 | Name: | (4-chloropyridin-2-yl)methanol | Formula: | C6 H6 Cl N O | SMILES: | Clc1ccnc(c1)CO | InChi: | InChI=1S/C6H6ClNO/c7-5-1-2-8-6(3-5)4-9/h1-3,9H,4H2 | Synonyms: | 4-chloro-2-hydroxymethylpyridine | Definition date: | 2011-04-14 | Last modified: | 2024-09-27 | Identifier: | (4-chloropyridin-2-yl)methanol |
|
 | HM7 | Name: | 3-methylthioethane-pyrazinedione | Formula: | C8 H10 N2 O3 S2 | SMILES: | O=C1N=C(O)C(=NC1=C(/S)O)CCSC | InChi: | InChI=1S/C8H10N2O3S2/c1-15-3-2-4-6(11)10-7(12)5(9-4)8(13)14/h13-14H,2-3H2,1H3,(H,10,11,12)/b8-5- | Definition date: | 2011-04-18 | Last modified: | 2024-09-27 | Identifier: | (3Z)-6-hydroxy-3-[hydroxy(sulfanyl)methylidene]-5-[2-(methylsulfanyl)ethyl]pyrazin-2(3H)-one |
|
 | HM8 | Name: | 2-[(1S,2R)-1-amino-2-(sulfooxy)propyl]-5-hydroxy-1,3-oxazole-4-carbothioic O-acid | Formula: | C7 H10 N2 O7 S2 | SMILES: | S=C(O)c1nc(oc1O)C(N)C(OS(=O)(=O)O)C | InChi: | InChI=1S/C7H10N2O7S2/c1-2(16-18(12,13)14)3(8)5-9-4(7(11)17)6(10)15-5/h2-3,10H,8H2,1H3,(H,11,17)(H,12,13,14)/t2-,3+/m1/s1 | Definition date: | 2011-04-18 | Last modified: | 2024-09-27 | Identifier: | 2-[(1S,2R)-1-amino-2-(sulfooxy)propyl]-5-hydroxy-1,3-oxazole-4-carbothioic O-acid |
|
 | HM9 | Name: | 6-(3-CARBAMIMIDAMIDOPROPYL)-3,5-DIHYDROXYPYRAZINE-2-CARBOTHIOIC S-ACID | Formula: | C9 H13 N5 O3 S | SMILES: | O=C(S)c1nc(c(O)nc1O)CCCNC(=[N@H])N | InChi: | InChI=1S/C9H13N5O3S/c10-9(11)12-3-1-2-4-6(15)14-7(16)5(13-4)8(17)18/h1-3H2,(H,17,18)(H4,10,11,12)(H2,14,15,16) | Definition date: | 2011-04-18 | Last modified: | 2024-09-27 | Identifier: | 6-(3-carbamimidamidopropyl)-3,5-dihydroxypyrazine-2-carbothioic S-acid |
|
 | HMB | Name: | (4S)-4-hydroxy-4-methoxybutanoic acid | Formula: | C5 H10 O4 | SMILES: | O=C(O)CCC(O)OC | InChi: | InChI=1S/C5H10O4/c1-9-5(8)3-2-4(6)7/h5,8H,2-3H2,1H3,(H,6,7)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (4S)-4-hydroxy-4-methoxybutanoic acid |
|
 | HMF | Name: | 2-AMINO-4-PHENYL-BUTYRIC ACID | Formula: | C10 H13 N O2 | SMILES: | O=C(O)C(N)CCc1ccccc1 | InChi: | InChI=1S/C10H13NO2/c11-9(10(12)13)7-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m1/s1 | Synonyms: | D-BETA-HOMOPHENYLALANINE | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-amino-4-phenylbutanoic acid |
|
 | HMG | Name: | 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A | Formula: | C27 H39 N7 O20 P3 S | SMILES: | [O-]C(=O)CC(O)(C)CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP([O-])(=O)OP([O-])(=O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP([O-])([O-])=O | InChi: | InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/p-5/t14-,19-,20-,21+,25-,27+/m1/s1 | Synonyms: | (S)-HMG-COA | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (9R,21S)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)tetrahydrofuran-2-yl]-9,21-dihydroxy-8,8,21-trimethyl-3,5-dioxido-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphatricosan-23-oate 3,5-dioxide (non-preferred name) |
|
 | HMR | Name: | BETA-HOMOARGININE | Formula: | C7 H16 N4 O2 | SMILES: | O=C(O)CC(N)CCCNC(=[N@H])N | InChi: | InChI=1S/C7H16N4O2/c8-5(4-6(12)13)2-1-3-11-7(9)10/h5H,1-4,8H2,(H,12,13)(H4,9,10,11)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-amino-6-carbamimidamidohexanoic acid |
|
 | HMY | Name: | (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione | Formula: | C19 H22 O8 | SMILES: | O=C3C=CCC(OC(=O)c1c(cc(OC)cc1O)C2OC2CC(O)C3O)C | InChi: | InChI=1S/C19H22O8/c1-9-4-3-5-12(20)17(23)14(22)8-15-18(27-15)11-6-10(25-2)7-13(21)16(11)19(24)26-9/h3,5-7,9,14-15,17-18,21-23H,4,8H2,1-2H3/t9-,14-,15+,17+,18+/m0/s1 | Synonyms: | Hypothemycin | Definition date: | 2008-02-19 | Last modified: | 2024-09-27 | Identifier: | (1aR,8S,10Z,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione |
|
 | HNC | Name: | S-[(1S,2R)-2-hydroxy-1-(2-oxoethyl)heptyl]-L-cysteine | Formula: | C12 H23 N O4 S | SMILES: | O=C(O)C(N)CSC(C(O)CCCCC)CC=O | InChi: | InChI=1S/C12H23NO4S/c1-2-3-4-5-10(15)11(6-7-14)18-8-9(13)12(16)17/h7,9-11,15H,2-6,8,13H2,1H3,(H,16,17)/t9-,10+,11-/m0/s1 | Synonyms: | Cysteine covalently modified with 4-hydroxy-2-nonenal | Definition date: | 2009-09-17 | Last modified: | 2024-09-27 | Identifier: | S-[(3S,4R)-4-hydroxy-1-oxononan-3-yl]-L-cysteine |
|
 | KWS | Name: | {2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-methylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C9 H13 N3 O4 | SMILES: | O=C1C(N=C(N1CC(=O)O)C(N)C(O)C)=C | InChi: | InChI=1S/C9H13N3O4/c1-4-9(16)12(3-6(14)15)8(11-4)7(10)5(2)13/h5,7,13H,1,3,10H2,2H3,(H,14,15)/t5-,7+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2011-11-18 | Last modified: | 2024-09-27 | Identifier: | {2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-methylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | KWT | Name: | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,
3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE | Formula: | C23 H24 O8 | SMILES: | O=C3c2occ1C(=O)OC(C(c12)(C5=C3C4C(C(=O)CC4)(C)CC5OC(=O)C)C)COC | InChi: | InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 | Synonyms: | [1S-(1A,6BA,9AB,11A,11BB)]-11-(ACETYLOXY)-1,6B,7,8,9A,10,11,11B-OCTAHYDRO-1-(METHOXYMETHLY)
-9A,11B-DIMETHYL-3H-FURO[4,3,2-DE]INDENL[4,5-H]-2-BENZOPYRAN-3,6,9,TRIONE | Definition date: | 2000-09-11 | Last modified: | 2024-09-27 | Identifier: | (1S,6bR,9aS,11R,11bR)-1-(methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate |
|
 | HNE | Name: | (2E,4R)-4-HYDROXYNON-2-ENAL | Formula: | C9 H16 O2 | SMILES: | O=C/C=C/C(O)CCCCC | InChi: | InChI=1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3/b7-5+/t9-/m1/s1 | Definition date: | 2006-08-22 | Last modified: | 2024-09-27 | Identifier: | (2E,4R)-4-hydroxynon-2-enal |
|
 | KWZ | Name: | 4-(3-piperidin-1-ylpropyl)-6-[3-(trifluoromethyl)phenyl]pyrimidine-2-carbonitrile | Formula: | C20 H21 F3 N4 | SMILES: | FC(F)(F)c1cccc(c1)c2cc(CCCN3CCCCC3)nc(n2)C#N | InChi: | InChI=1S/C20H21F3N4/c21-20(22,23)16-7-4-6-15(12-16)18-13-17(25-19(14-24)26-18)8-5-11-27-9-2-1-3-10-27/h4,6-7,12-13H,1-3,5,8-11H2 | Definition date: | 2009-12-09 | Last modified: | 2024-09-27 | Identifier: | 4-(3-piperidin-1-ylpropyl)-6-[3-(trifluoromethyl)phenyl]pyrimidine-2-carbonitrile |
|
 | HNO | Name: | N-tert-butyl-6,7-bis(chloranyl)quinoxalin-2-amine | Formula: | C12 H13 Cl2 N3 | SMILES: | CC(C)(C)Nc1cnc2cc(Cl)c(Cl)cc2n1 | InChi: | InChI=1S/C12H13Cl2N3/c1-12(2,3)17-11-6-15-9-4-7(13)8(14)5-10(9)16-11/h4-6H,1-3H3,(H,16,17) | Definition date: | 2021-01-20 | Last modified: | 2024-09-27 | Release date: | 2021-07-07 | Identifier: | ~{N}-~{tert}-butyl-6,7-bis(chloranyl)quinoxalin-2-amine |
|
 | KXL | Name: | (2S)-N-[(2S)-1-(dimethylamino)-1-oxidanylidene-3-phenyl-propan-2-yl]-2-oxidanyl-N'-(2-pyridin-2-ylethyl)butanediamide | Formula: | C22 H28 N4 O4 | SMILES: | CN(C)C(=O)[CH](Cc1ccccc1)NC(=O)[CH](O)CC(=O)NCCc2ccccn2 | InChi: | InChI=1S/C22H28N4O4/c1-26(2)22(30)18(14-16-8-4-3-5-9-16)25-21(29)19(27)15-20(28)24-13-11-17-10-6-7-12-23-17/h3-10,12,18-19,27H,11,13-15H2,1-2H3,(H,24,28)(H,25,29)/t18-,19-/m0/s1 | Definition date: | 2022-06-07 | Last modified: | 2024-09-27 | Release date: | 2023-11-29 | Identifier: | (2~{S})-~{N}-[(2~{S})-1-(dimethylamino)-1-oxidanylidene-3-phenyl-propan-2-yl]-2-oxidanyl-~{N}'-(2-pyridin-2-ylethyl)butanediamide |
|
 | HOA | Name: | HYDROXYAMINE | Formula: | H3 N O | SMILES: | ON | InChi: | InChI=1S/H3NO/c1-2/h2H,1H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | hydroxylamine |
|
 | KXV | Name: | {(4Z)-2-[(1R)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-methoxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}ac
etic acid | Formula: | C15 H17 N3 O5 S | SMILES: | NC(CS)C=1N(CC(=O)O)C(=O)C(N=1)=[C@H]c2ccc(c(c2)OC)O | InChi: | InChI=1S/C15H17N3O5S/c1-23-12-5-8(2-3-11(12)19)4-10-15(22)18(6-13(20)21)14(17-10)9(16)7-24/h2-5,9,19,24H,6-7,16H2,1H3,(H,20,21)/b10-4-/t9-/m0/s1 | Synonyms: | CHROMOPHORE (CYS-TYR-GLY)-3-OMeY | Definition date: | 2019-01-23 | Last modified: | 2024-09-27 | Release date: | 2019-06-12 | Identifier: | {(4Z)-2-[(1R)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-methoxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | KY4 | Name: | {(4Z)-2-[(1R)-1-amino-2-sulfanylethyl]-4-[(2,3-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C14 H13 F2 N3 O4 S | SMILES: | NC(CS)C1=N/C(C(N1CC(O)=O)=O)=Cc2c(F)c(F)c(cc2)O | InChi: | InChI=1S/C14H13F2N3O4S/c15-11-6(1-2-9(20)12(11)16)3-8-14(23)19(4-10(21)22)13(18-8)7(17)5-24/h1-3,7,20,24H,4-5,17H2,(H,21,22)/b8-3-/t7-/m0/s1 | Synonyms: | CHROMOPHORE (CYS-TYR-GLY)-2,3-F | Definition date: | 2019-01-23 | Last modified: | 2024-09-27 | Release date: | 2019-06-12 | Identifier: | {(4Z)-2-[(1R)-1-amino-2-sulfanylethyl]-4-[(2,3-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | HOM | Name: | 7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN | Formula: | C12 H12 O4 | SMILES: | O=C2Oc1cc(O)ccc1C(=C2CCO)C | InChi: | InChI=1S/C12H12O4/c1-7-9-3-2-8(14)6-11(9)16-12(15)10(7)4-5-13/h2-3,6,13-14H,4-5H2,1H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 7-hydroxy-3-(2-hydroxyethyl)-4-methyl-2H-chromen-2-one |
|
 | HOO | Name: | (2~{S})-2-azanyl-3-[2,5-bis(oxidanylidene)imidazol-4-yl]propanoic acid | Formula: | C6 H7 N3 O4 | SMILES: | N[CH](CC1=NC(=O)NC1=O)C(O)=O | InChi: | InChI=1S/C6H7N3O4/c7-2(5(11)12)1-3-4(10)9-6(13)8-3/h2H,1,7H2,(H,11,12)(H,9,10,13)/t2-/m0/s1 | Definition date: | 2018-06-07 | Last modified: | 2024-09-27 | Release date: | 2019-02-27 | Identifier: | (2~{S})-2-azanyl-3-[2,5-bis(oxidanylidene)imidazol-4-yl]propanoic acid |
|